BPC-157: What the Actual Human Evidence Shows

BPC-157 is one of the most talked-about peptides in wellness and sports-recovery circles, so this systematic review is a useful reality check. Following PRISMA methodology, the authors searched PubMed, Cochrane and Embase for all English-language literature on BPC-157 in orthopaedic and sports medicine contexts. Of 544 articles identified, only one human clinical study met the inclusion criteria for the review; the overwhelming majority of the evidence for tendon, ligament and muscle healing comes from animal models, chiefly rats. Within those animal studies, the findings were consistent and favourable: reduced instability after tendon injury, faster restoration of normal movement, and a favourable safety profile in preclinical settings. But the authors are explicit that human safety data simply does not yet exist at any meaningful scale, and they caution clinicians and athletes against use given how thin the clinical evidence base remains. This is the current, honest state of the science, not a case against BPC-157 specifically, but a case for waiting on real human trials.